Nuveen Asset Management, LLC Orchard Therapeutics PLC Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.86 - $5.07 $377,832 - $496,271	-97,884 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $120,801 - $251,897	-21,009 Reduced 17.67%	97,884 $587,000
Q1 2020 May 14, 2020	SELL	$5.65 - $15.71 $210,626 - $585,653	-37,279 Reduced 23.87%	118,893 $895,000
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $25,080 - $38,498	-2,471 Reduced 1.56%	156,172 $2.15 Million
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $1.88 Million - $2.65 Million	158,643 New	158,643 $1.89 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.